Cargando…

Progesterone and progestogens

Detalles Bibliográficos
Autor principal:	Lipinski, Joanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	NPS MedicineWise 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427621/ https://www.ncbi.nlm.nih.gov/pubmed/36110173 http://dx.doi.org/10.18773/austprescr.2022.047

Ejemplares similares

Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review
por: Donnez, Jacques, et al.
Publicado: (2021)

Acute urticaria: an extremely rare adverse effect of levonorgestrel-releasing intrauterine system as a possible manifestation of progestogen hypersensitivity syndrome
por: Emeryk-Maksymiuk, Justyna, et al.
Publicado: (2018)

Progestogens in menopausal hormone therapy
por: Bińkowska, Małgorzata, et al.
Publicado: (2015)

Bridging progestogens in pregnancy and pregnancy prevention
por: Micks, Elizabeth, et al.
Publicado: (2015)

The Role Of Progestogens In Threatened And Idiopathic Recurrent Miscarriage
por: Arab, Hisham, et al.
Publicado: (2019)

Solving the Puzzle: What Is the Role of Progestogens in Neovascularization?
por: Xia, Zhi, et al.
Publicado: (2021)

Progesterone supplementation – Beware of changes in the oral cavity
por: Singh, Preetinder, et al.
Publicado: (2013)

Endogenous progesterone levels could predict reproductive outcome in frozen embryo replacement cycles supplemented with synthetic progestogens: A retrospective cohort study
por: Kawachiya, Satoshi, et al.
Publicado: (2018)

Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy
por: Douxfils, Jonathan, et al.
Publicado: (2023)

Comment on ‘Renewed interest in the progesterone receptor in breast cancer’
por: Simone, Giovanni, et al.
Publicado: (2017)

Successful Experience of Cyclic Progesterone Supplementation in Catamenial Epilepsy
por: Kim, Jon Soo, et al.
Publicado: (2020)

The Role of Progestogens in Threatened and Idiopathic Recurrent Miscarriage [Corrigendum]
Publicado: (2020)

A case of recurrent retroperitoneal lymphangioleiomyomatosis treated with progesterone therapy
por: Basnet, Alina, et al.
Publicado: (2015)

Progestogen-only oral contraceptives: Number 4 - April 2022
por: Machado, Rogério Bonassi, et al.
Publicado: (2022)

The Use of Progestogen in the Treatment of Metastatic Carcinoma of the Kidney and Uterine Body
por: Paine, C. H., et al.
Publicado: (1970)

Progestogens Are Metabolized by the Gut Microbiota: Implications for Colonic Drug Delivery
por: Coombes, Zoe, et al.
Publicado: (2020)

Estrogens and Progestogens in Triple Negative Breast Cancer: Do They Harm?
por: van Barele, Mark, et al.
Publicado: (2021)

FIGO good practice recommendations on progestogens for prevention of preterm delivery
por: Shennan, Andrew, et al.
Publicado: (2021)

Prevention of Pregnancy Loss: Combining Progestogen Treatment and Psychological Support
por: Tetruashvili, Nana, et al.
Publicado: (2023)

Estro-progestin and progestogen intake: What’s the impact on hysteroscopic imaging?
por: Garuti, G, et al.
Publicado: (2023)

If Progesterone Is Blamed for Breast Cancer Development, Why Are We Still Using Tamoxifen?
por: Özkaya, Enis, et al.
Publicado: (2013)

Effectiveness and acceptability of progestogens in combined oral contraceptives – a systematic review
por: Kulier, Regina, et al.
Publicado: (2004)

Identification of new progestogen-associated networks in mammalian ovulation using bioinformatics
por: Yang, Fang, et al.
Publicado: (2018)

The clinical relevance of progestogens in hormonal contraception: Present status and future developments
por: Regidor, Pedro-Antonio
Publicado: (2018)

Neuroprotection of reduced thyroid hormone with increased estrogen and progestogen in postpartum depression
por: Li, Dan, et al.
Publicado: (2019)

Menopausal hormone therapy and breast cancer risk: All progestogens are not the same
por: Lambrinoudaki, Irene
Publicado: (2020)

Estetrol Combined to Progestogen for Menopause or Contraception Indication Is Neutral on Breast Cancer
por: Gallez, Anne, et al.
Publicado: (2021)

Uterine uptake of estrogen and progestogen-based radiotracers in rhesus macaques with endometriosis
por: Wilson, Rachel Catharine, et al.
Publicado: (2023)

The protective side of progesterone
por: Ferretti, Gianluigi, et al.
Publicado: (2007)

Hormonal contraception in women with migraine: is progestogen-only contraception a better choice?
por: Nappi, Rossella E, et al.
Publicado: (2013)

Antiandrogenic and antimineralocorticoid health benefits of COC containing newer progestogens: dienogest and drospirenone
por: Regidor, Pedro-Antonio, et al.
Publicado: (2017)

Effectiveness of Progestogens as Maintenance Tocolysis and Urogenital Cultures: Secondary Analysis of the PROTECT Trial
por: Pignatti, Lucrezia, et al.
Publicado: (2020)

Progestogens as a component of menopausal hormone therapy: the right molecule makes the difference
por: Stevenson, John C, et al.
Publicado: (2020)

Uterine Fibroids and Progestogen Treatment: Lack of Evidence of Its Efficacy: A Review
por: Donnez, Jacques
Publicado: (2020)

Progestogens for maintenance tocolysis in symptomatic women. A systematic review and meta-analysis
por: Ferrari, Francesca, et al.
Publicado: (2023)

Comment on “Application of an in Vitro Assay to Identify Chemicals That Increase Estradiol and Progesterone Synthesis and Are Potential Breast Cancer Risk Factors”
por: Burgoon, Lyle D., et al.
Publicado: (2022)

Postmenopausal Hormone Therapy and Risk of Stroke: Impact of the Route of Estrogen Administration and Type of Progestogen
por: Canonico, Marianne, et al.
Publicado: (2016)

Diestrous Ovulations in Pregnant Mares as a Response to Low Early Postovulatory Progestogen Concentration
por: Okada, Carolina T. C., et al.
Publicado: (2020)

Progestogen metabolites for use in pregnancy monitoring of 13-lined ground squirrels (Ictidomys tridecemlineatus)
por: Miller, Amy, et al.
Publicado: (2021)

Mitigating the economic burden of GnRH agonist therapy for progestogen-resistant endometriosis: why not?
por: Vercellini, Paolo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fujlbsm62n9ugjo96a630infko